Table 4.
Outcomes for all patients and for patients classified according to the maximum Risk, Injury, Failure, Loss, and End-stage Kidney (RIFLE) class
No acute kidney injury (n = 1,766) | Risk (n = 670) | Injury (n = 1,436) | Failure (n = 1,511) | All injury (n = 5,383) | |
Renal replacement therapy* | 1 (0.1%) | 0 (0%) | 4 (0.3%) | 214 (14.2%) | 219 (4.1%) |
Hospital LOS after reaching maximum RIFLE class (days)* | 5 (3–10) | 5 (3–10) | 7 (4–14) | 11 (5–23) | 7 (3–14) |
ICU LOS (days)* | 3 (2–4) | 3 (2–6) | 5 (3–10) | 9 (4–21) | 4 (2–9) |
Hospital LOS (days)* | 6 (4–10) | 8 (5–14) | 10 (6–19) | 16 (9–31) | 9 (5–19) |
Hospital mortality* | 97 (5.5%) | 59 (8.8%) | 163 (11.4%) | 398 (26.3%) | 717 (13.3%) |
Continuous variables presented as the median (interquartile interval) and categorical variables presented as the percentage. LOS, length of stay; ICU, intensive care unit. *P = 0.001 between the four subgroups no acute kidney injury, RIFLE class risk, RIFLE class injury and RIFLE class failure.